Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xtoro in Acute Otitis Externa
NCT01535560Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of finafloxacin in acute otitis externa (AOE), sponsored by Alcon Inc.. Started Apr 2012; status: completed.
02
Drugs
finafloxacin
03
Conditions
acute otitis externa (AOE)
Beyond the preview
Go deeper on NCT01535560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535560.